Our mission
Our vision
KINSY, your End-to-End European CDMO for APIs & Intermediates.
KINSY, your End-to-End European CDMO for APIs & Intermediates. We will exhibit at ChemOutsouring. Please, visit our booth#51. Our services: -From Early Clinical Stages to
KINSY will exhibit at BIO International Convention Boston
KINSY will exhibit at BIO International Convention Boston KINSY will exhibit at BIO International Convention Boston, Massachusetts. Please, visit our booth ICEX, Spain Trade &
Contact
Factory
KINSY, S.L. Av. Europa s/n (Parque Ind. de Alhama).
30840 Alhama de Murcia
Murcia, Spain.
+34 968 632 333
Headquarters and administration
KINSY S.L. Gran Vía 15, 4º
30004 Murcia, Spain
+34 968 217 608
info@kinsy.es
- Responsible for treatment: Your data will be processed by KINSY, S.L. with registered office at Gran Vía, 15, 4º, 30004 – Murcia (Murcia).
- Purpose and legitimacy: Your data will be processed for the purposes specified in the reason for contact and to respond to your requests or queries, based on legal express consent.
- Assignments: they will not be transferred to third parties except legal obligation.
- Term: Your data will be processed for the time strictly necessary for the fulfillment of the specific purpose or purposes that motivated its collection, until the loss of relevance of its use or, in any case, until it is canceled in response to the exercise by its holder of the corresponding rights.
- Rights: We inform you that you can exercise your rights of access, rectification, cancellation and opposition to the treatment of your data through this contact form or by going to the following email address: info@kinsy.es, or also in writing, attaching a copy of a document proving your identity to the address: Gran Vía, 15, 4º,, 30004 – Murcia (Murcia)
- Additional information: You can consult additional and detailed information on Data Protection in our privacy policy.
Regional Incentives Exp: MU-1577-P02
The new facilities of the company KINSY SOCIEDAD LIMITADA, dedicated to the manufacture of pharmaceutical active ingredients, have received a grant from the Regional Incentives aid program for the acquisition of capital goods through file MU-1577-PO2. This aid has been co-financed by the European Regional Development Fund (ERDF 2021–2027).
KINSY S.L. has increased its production capacity, achieving greater competitiveness and productivity through the incorporation of new capital goods, under file MU-1577-PO2, whose investment has been subsidized by the Regional Incentives aid program. This aid has been co-financed by the European Regional Development Fund. The project aims to expand the company’s production capacity through the implementation of new synthesis lines, with an investment of €3.89 million, addressing the demand for fine chemicals and APIs. All of this is being achieved through advanced technology and qualified personnel, which will increase production, revenue, and profitability. As a result, Kinsy will strengthen its competitiveness, consolidating its position as a benchmark in the pharmaceutical sector.
